Hims & Hers Health, Inc. (HIMS)

Market Cap	6.06B -53.3%
Revenue (ttm)	2.37B +32.8%
Net Income	-13.24M
EPS	-0.06
Shares Out	231.46M
PE Ratio	n/a
Forward PE	89.60
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,705,868
Open	27.10
Previous Close	28.01
Day's Range	25.40 - 27.89
52-Week Range	13.74 - 70.43
Beta	2.40
Analysts	Hold
Price Target	26.61 (+1.6%)
Earnings Date	May 11, 2026

About HIMS

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and de...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Employees: 2,442
• Stock Exchange: NYSE
• Ticker Symbol: HIMS
• Website: https://www.hims.com

Financial Performance

In 2025, Hims & Hers Health's revenue was $2.35 billion, an increase of 59.00% compared to the previous year's $1.48 billion. Earnings were $128.37 million, an increase of 1.85%.

Analyst Summary

According to 16 analysts, the average rating for HIMS stock is "Hold." The 12-month stock price target is $26.61, which is an increase of 1.60% from the latest price.

Price Target

$26.61

(1.60% upside)

Analyst Consensus: Hold